A possible therapeutic approach to Krabbe's globoid leukodystrophy and the status of cerebroside synthesis in the disorder.
D000217:Acyltransferases / Q000378:metabolism; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D000440:Butanols / Q000494:pharmacology / Q000627:therapeutic use; D002554:Cerebrosides / Q000096:biosynthesis* / Q000627:therapeutic use; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D004285:Dogs; D004789:Enzyme Activation / Q000187:drug effects; D005227:Fatty Acids / Q000627:therapeutic use; D005233:Fatty Alcohols / Q000494:pharmacology / Q000627:therapeutic use; D005696:Galactosidases / Q000378:metabolism; D006602:Hexosyltransferases / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D013268:Stimulation, Chemical
D000605:Amino Alcohols; D000440:Butanols; D002554:Cerebrosides; D005227:Fatty Acids; D005233:Fatty Alcohols; D000217:Acyltransferases; D006602:Hexosyltransferases; D005696:Galactosidases